MedPath

A Single-Center, Prospective, Open Labeled, Phase IV Clinical Study to Evaluate Safety and Efficacy of MY V3 Immune Herbal Capsules in Healthy Participants.

Phase 4
Registration Number
CTRI/2024/05/067457
Lead Sponsor
Sidhva Herbal and Foods Pondicherry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Male/females of greater than or equal to 18 years of age at the time of consent

2) Patient / Legally Acceptable Representative who can and willing to provide Informed Consent

3) Confirmed anemia

4) Clinically stable for at least 1 month prior to entry into the study

5) Score on the Insomnia Severity Index (ISI) measure greater than or equal to 15

Exclusion Criteria

1) Pregnant or lactating women or women of childbearing potential who did not use oral contraceptives or an intrauterine device

2) Administration of another investigational drug within 1 month before screening or planned during the study period

3) Patients who, in the judgment of the investigator, will be unlikely to comply with the requirements of this protocol

4) Diagnosis of other primary sleep disorders

5) Psychotherapy within the past six months

6) Shift workers

7) Current or expected use of hypnotic medications

8) Renal or hepatic disease

9) History of Neurological disorder or cardiovascular disease raising safety concerns

10) Excessive coffee or cigarette use

11) Recent surgery

12) Current alcohol/substance use disorder

13) Current major depressive episode

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath